Your browser doesn't support javascript.
loading
Novel Ran-RCC1 Inhibitory Peptide-Loaded Nanoparticles Have Anti-Cancer Efficacy In Vitro and In Vivo.
Haggag, Yusuf A; Matchett, Kyle B; Falconer, Robert A; Isreb, Mohammad; Jones, Jason; Faheem, Ahmed; McCarron, Paul; El-Tanani, Mohamed.
Afiliación
  • Haggag YA; Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Tanta, Tanta 31111, Egypt. youssif.hagag@pharm.tanta.edu.eg.
  • Matchett KB; School of Pharmacy and Pharmaceutical Sciences, Saad Centre for Pharmacy and Diabetes, Ulster University, Cromore Road, Coleraine, Co. Londonderry BT52 1SA, UK. youssif.hagag@pharm.tanta.edu.eg.
  • Falconer RA; Northern Ireland Centre for Stratified Medicine, School of Biomedical Sciences, C-TRIC, Altnagelvin Hospital Campus, Ulster University, Glenshane Road, Derry/Londonderry BT47 6SB, Northern Ireland, UK. k.matchett@ulster.ac.uk.
  • Isreb M; Institute of Cancer Therapeutics, Faculty of Life Sciences, University of Bradford, Bradford BD7 1DP, UK. r.a.falconer1@bradford.ac.uk.
  • Jones J; School of Pharmacy and Clinical Sciences, University of Bradford, Bradford BD7 1DP, UK. M.Isreb1@bradford.ac.uk.
  • Faheem A; Institute of Cancer Therapeutics, Faculty of Life Sciences, University of Bradford, Bradford BD7 1DP, UK. J.R.Jones@bradford.ac.uk.
  • McCarron P; Department of Pharmacy, Health and Well-being, University of Sunderland, Sunderland SR1 3SD, UK. ahmed.faheem@sunderland.ac.uk.
  • El-Tanani M; School of Pharmacy and Pharmaceutical Sciences, Saad Centre for Pharmacy and Diabetes, Ulster University, Cromore Road, Coleraine, Co. Londonderry BT52 1SA, UK. p.mccarron@ulster.ac.uk.
Cancers (Basel) ; 11(2)2019 Feb 14.
Article en En | MEDLINE | ID: mdl-30769871

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancers (Basel) Año: 2019 Tipo del documento: Article País de afiliación: Egipto Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancers (Basel) Año: 2019 Tipo del documento: Article País de afiliación: Egipto Pais de publicación: Suiza